XNW5004 Clinical Trials
2 recruitingDrug
Phase 12Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
mCRPC (Metastatic Castration-resistant Prostate Cancer)Metastatic Castrate Resistant Prostate Cancer
Evopoint Biosciences Inc.307 enrolled2 locationsNCT06702995
Recruiting
Phase 1Phase 2
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)
Cervical CancerProstate CancerUrothelial Carcinoma+5 more
Evopoint Biosciences Inc.204 enrolled1 locationNCT06022757